BindingDB Entry 50016846: Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome.

Name: BindingDB Entry 50016846: Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome.
Creator: BindingDB
Keywords: 11-beta-Hydroxysteroid Dehydrogenase 2 (11-beta-HSD2), 11-beta-hydroxysteroid dehydrogenase 1, and 11-beta-hydroxysteroid dehydrogenase 2, Merck & Co., Affinity

Research datakeyboard_double_arrow_right Dataset 01 Jan 2009 English Publisher:BindingDB

Authors: BindingDB;

doi: 10.7270/q2qc031m

BindingDB Entry 50016846: Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome.

- Summary
- Subjects
- Related research
  (19)
- Metrics

tips_and_updates
Recommended

Abstract

Small molecule binding data for protein 11-beta-Hydroxysteroid Dehydrogenase 2 (11-beta-HSD2), 11-beta-hydroxysteroid dehydrogenase 1, and 11-beta-hydroxysteroid dehydrogenase 2, Uniprot P28845, P50172, P51661, and P80365

Keywords

11-beta-Hydroxysteroid Dehydrogenase 2 (11-beta-HSD2), 11-beta-hydroxysteroid dehydrogenase 1, and 11-beta-hydroxysteroid dehydrogenase 2, Merck & Co., Affinity

19 Research products, page 1 of 2

BindingDB Entry 50019128: Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
2009IsAmongTopNSimilarDocuments
BindingDB Entry 50039828: Cycloartane and friedelane triterpenoids from the leaves of Caloncoba glauca and their evaluation for inhibition of 11ß-hydroxysteroid dehydrogenases.
2013IsAmongTopNSimilarDocuments
BindingDB Entry 50043169: Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11ß-HSD1 inhibitors: potential impact in diabetes.
2014IsAmongTopNSimilarDocuments
BindingDB Entry 50018206: Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitors.
2009IsAmongTopNSimilarDocuments
BindingDB Entry 50038535: Phenylcyclobutyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
2012IsAmongTopNSimilarDocuments
BindingDB Entry 50044437: Medicinal chemistry of inhibitors of 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1).
2015IsAmongTopNSimilarDocuments
BindingDB Entry 50033172: Substituted phenyl triazoles as selective inhibitors of 11ß-Hydroxysteroid Dehydrogenase Type 1.
2011IsAmongTopNSimilarDocuments
BindingDB Entry 50018275: Discovery of orally active butyrolactam 11beta-HSD1 inhibitors.
2009IsAmongTopNSimilarDocuments
BindingDB Entry 1733: Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluation.
2007IsAmongTopNSimilarDocuments
BindingDB Entry 50033148: Bicyclo[2.2.2]octyltriazole inhibitors of 11ß-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome.
2011IsAmongTopNSimilarDocuments

chevron_left
1
2
chevron_right

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average